Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000921506-99-000005
Filing Date
1999-05-12
Accepted
1999-05-12 00:00:00
Documents
10
Period of Report
1999-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q 10-Q 34663
2 EXECUTIVE SEVERANCE BENEFITS AGREEMENT EX-10.57 28132
3 EXECUTIVE SEVERANCE BENEFITS AGREEMENT EX-10.58 28199
4 EXECUTIVE SEVERANCE BENEFITS AGREEMENT EX-10.59 28174
5 EXECUTIVE SEVERANCE BENEFITS AGREEMENT EX-10.60 28179
6 EXECUTIVE SEVERANCE BENEFITS AGREEMENT EX-10.61 28189
7 EXECUTIVE SEVERANCE BENEFITS AGREEMENT EX-10.62 28174
8 EXECUTIVE SEVERANCE BENEFITS AGREEMENT EX-10.63 28185
9 EXECUTIVE SEVERANCE BENEFITS AGREEMENT EX-10.64 28179
10 EXHIBIT 27.1 (FDS) EX-27.1 2375
  Complete submission text file 0000921506-99-000005.txt   264890
Mailing Address 3172 PORTER DRIVE PALO ALTO CA 94304
Business Address 3172 PORTER DR PALO ALTO CA 94304 6508120585
CV THERAPEUTICS INC (Filer) CIK: 0000921506 (see all company filings)

EIN.: 431570294 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21643 | Film No.: 99617760
SIC: 8731 Services-Commercial Physical & Biological Research